dUTPase: the frequently overlooked enzyme encoded by many retroviruses by unknown
Hizi and Herzig  Retrovirology  (2015) 12:70 
DOI 10.1186/s12977-015-0198-9
REVIEW
dUTPase: the frequently overlooked 
enzyme encoded by many retroviruses
Amnon Hizi* and Eytan Herzig
Abstract 
Retroviruses are among the best studied viruses in last decades due to their pivotal involvement in cellular processes 
and, most importantly, in causing human diseases, most notably—acquired immunodeficiency syndrome (AIDS) that 
is triggered by human immunodeficiency viruses types 1 and 2 (HIV-1 and HIV-2, respectively). Numerous studied 
were conducted to understand the involvement of the three cardinal retroviral enzymes, reverse transcriptase, inte-
grase and protease, in the life cycle of the viruses. These studies have led to the development of many inhibitors of 
these enzymes as anti-retroviral specific drugs that are used for routine treatments of HIV/AIDS patients. Interestingly, 
a fourth virus-encoded enzyme, the deoxyuridine 5′-triphosphate nucleotidohydrolase (dUTPase) is also found in 
several major retroviral groups. The presence and the importance of this enzyme to the life cycle of retroviruses were 
usually overlooked by most retrovirologists, although the occurrence of dUTPases, particularly in beta-retroviruses and 
in non-primate retroviruses, is known for more than 20 years. Only more recently, retroviral dUTPases were brought 
into the limelight and were shown in several cases to be essential for viral replication. Therefore, it is likely that future 
studies on this enzyme will advance our knowledge to a level that will allow designing novel, specific and potent 
anti-dUTPase drugs that are effective in combating retroviral diseases. The aim of this review is to give concise back-
ground information on dUTPases in general and to summarize the most relevant data on retroviral dUTPases and their 
involvement in the replication processes and pathogenicity of the viruses, as well as in possibly-associated human 
diseases.
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Background
The hallmark of all retroviruses is their replication 
strategy that relies on two critical steps. The first is the 
reverse transcription of the viral plus strand RNA into 
linear double-stranded DNA that is catalyzed by the viral 
reverse transcriptase (RT). The second step occurs when 
the synthesized DNA is subsequently integrated by the 
viral integrase (IN) enzyme into the cell genomic DNA 
[1–4]. After integration, the proviral DNA becomes a part 
of the cellular genomic DNA. The genome of all retrovi-
ruses is organized in three major distinct genes: gag, pol 
and env. In most retroviruses, the pol gene encodes for 
all three basic retroviral enzymes, the protease (PR), RT 
and IN [1]. Due to the critical role of these three retrovi-
ral enzymes in the viral cycle, a massive body of research 
was conducted on them. These studies were combined 
with a very extensive search for drugs effective against 
HIV, the AIDS causing retrovirus. This was done mainly 
by searching for selective inhibitors of the viral PR, RT 
and IN enzymes. Indeed, almost all anti-HIV/AIDS drugs 
that are currently used to treat patients are inhibitors of 
these three enzymes. In combination anti-HIV/AIDS 
therapies, several inhibitors (sometimes against more 
than one viral enzyme) are administered. Remarkably, 
relatively little attention was given to a fourth enzyme, 
encoded by several groups of retroviruses, the deoxyur-
idine 5′-triphosphate nucleotidohydrolase (dUTPase, EC 
3.6.1.23). This lack of attention results probably from the 
absence of dUTPases from those retroviruses that were 
the most heavily studied so far (such as, HIV and other 
Open Access
*Correspondence:  ahizy@post.tau.ac.il 
Department of Cell and Developmental Biology, Sackler School 
of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel
Page 2 of 15Hizi and Herzig  Retrovirology  (2015) 12:70 
primate lentiviruses, gamma-retroviruses or the alpha-
retroviruses). Thus, even reviews on retroviruses usually 
overlook this enzyme.
Cellular dUTPases hydrolyze dUTP into two products, 
dUMP and pyrophosphate (PPi). Subsequently, the prod-
uct dUMP is used as a substrate for thymidylate synthase 
in the major biosynthesis pathway to dTTP. Therefore, 
dUTPases have essential roles in preserving low cellular 
dUTP over dTTP ratios [5–7]. Lowering the intracellu-
lar dUTP/dTTP ratios obstructs dUTP misincorporation 
into DNA, since most DNA polymerases can use dUTP 
instead of dTTP for DNA synthesis, a process that may 
result in introducing mutations into the synthesized 
DNA (Fig. 1). To keep uracil residues out of DNA, most 
organisms, both prokaryotes and eukaryotes, as well as 
several DNA viruses (e.g., herpesviruses and poxviruses) 
and some groups of retroviruses, encode dUTPases that 
can be essential for their viability [5, 8, 9]. In this review, 
we will describe the most relevant information regarding 
the presence and functions of dUTPases in retroviruses 
and their involvement in the life cycle of the viruses and 
of the infected cells.
Review
Retroviruses and the retroviral life cycle
Most retroviruses belong to the ortho-retrovirinae sub-
family that is divided, according to genome organiza-
tion, into two major groups, the simple retroviruses 
and the complex ones [1]. All retroviruses contain three 
principal coding domains with information for virion 
proteins: (1) gag that directs the synthesis of internal 
virion proteins that usually form the matrix and cap-
sid structures. (2) Pol that encodes for the RT and IN 
enzymes. (3) Env that encodes for the surface and trans-
membrane glycoproteins of the viral envelope. An addi-
tional smaller domain that is present in all retroviruses is 
pro that encodes the viral protease. This pro gene can be 
part of the gag (as in the case of the alpha-retroviruses), 
as an independent gene (in the beta-retroviruses), or 
part of pol (as in gamma-retroviruses, lentiviruses or in 
delta-retroviruses) [1]. Simple retroviruses usually carry 
only this essential genomic information, whereas the 
complex retroviruses encode also for additional small 
regulatory proteins that are derived from multiply-
spliced viral mRNAs.
The most unique process in the life cycle of retrovi-
ruses is the complex reverse transcription step that takes 
place in the cytoplasm of the virus-infected cells [3, 4, 
10, 11]. After penetrating the target cells, the retroviral 
single-stranded plus-sense RNA, still contained within 
the viral core complex proteins, undergoes reverse tran-
scription. In this critical step, the viral RNA is copied into 
a double-stranded DNA by a combination of the enzy-
matic activities of the core-associated RT enzyme. These 
activities are the DNA polymerase, capable of copying 
both RNA and DNA, and the ribonucleases H (RNase 
H) that hydrolyzes the RNA template in RNA–DNA het-
eroduplexes formed during reverse transcription. This 
dUTP, dUTPases, mutagenesis and repair 
           dUTPase 
dUTP                        dUMP + PPi           Substrate for thymidylate synthase            dTTP 
    [This conversion maintains low dUTP/dTTP raos to minimize dUTP misincorporaon] 
dUTP misincorporates into DNA instead of dTTP 
            Mutagenesis of the DNA with dUTP             
      Repair of-                  Uracil-DNA glycosidase 
    Uracil containing DNA                                              DNA with apurinic (AP) sites 
                                                                                      AP endonuclease   
                                                                             Fill in single-base gaps by Pol β     
                                                             Ligaon of the nicked DNA by DNA ligase  
Fig. 1 A schematic description of the pathways for the introduction of dUTP into DNA and the repair of uracilated DNA.
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multi-step process involves also two template switches 
(or strand transfers) that result in a duplication of 
sequences located at the 5′ and 3′ ends of the virion RNA, 
so they are eventually fused in tandem to both ends of the 
generated viral DNA, forming the long terminal repeats 
(LTRs). After completion of DNA synthesis, the resulting 
product, still in complex with viral proteins (now called 
pre-integration complex—PIC), is translocated into the 
nucleus and the DNA is integrated into the host cell DNA 
by the enzymatic activities of the viral IN [2, 10, 12]. This 
integrated provirus becomes part of the cellular genome 
and, after activation, is transcribed into the viral mRNAs. 
The unspliced full-length RNA can serve as the viral 
progeny RNA genome. In addition, this mRNA and the 
spliced mRNA species are used to synthesize the various 
viral proteins.
After infection with simple retroviruses, the transcrip-
tion control is mediated primarily by interactions of 
cellular factors with the viral LTR, whereas in complex 
retroviruses, some viral regulatory proteins can affect 
transcription as well. Since most cells targeted by exog-
enous infective retroviruses can survive the infection, 
once integrated into germ cell genomes, the retroviral 
genomes can be transferred vertically in the infected 
animals for millions of years. These sequences of the 
endogenous retroviruses (ERVs), after being fixed in 
the evolutionary lineage, became integral part of most 
eukaryotic cells. Consequently, these endogenous viruses 
vastly outnumber the exogenous retroviruses [10, 13, 14]. 
Thus, human endogenous retroviruses (HERVs) consti-
tute nearly 8 % of the human genome [15, 16]. Many of 
these sequences were fixed in the germ line of old-world 
monkeys after their evolutionary separation from new-
world monkeys about 35 million years ago.
dUTPases in general
Cellular dUTPases (EC 3.6.1.23) hydrolyze dUTP to 
dUMP and PPi, thus serving two essential functions in 
DNA metabolism (Fig. 1). First, the dUMP product is a 
primary substrate for thymidylate synthase in the major 
dTTP biosynthesis pathway. Second, dUTPases help to 
maintain low intracellular dUTP/dTTP ratios. This is 
necessary to minimize the misincorporation of uracil into 
DNA, since most DNA polymerases (except for some 
archaeal enzymes) cannot distinguish between thymine 
and uracil and the uracil/thymine incorporation ratio 
depends on the relative level of dUTP and dTTP. The 
misincorporation into the synthesized DNA of the non-
canonical deoxyribo-nucleotide, dUTP, can eventually 
result in mutagenesis, for review, see [7, 9]. An excessive 
DNA repair of the uracilated DNA is initiated by uracil 
DNA glucosidases (UNG) that remove the uracil, form-
ing an apurinic DNA [7–9]. This DNA is then repaired by 
a chain of enzymatic activities of apurinic endonuclease, 
DNA polymerase beta and DNA ligase (Fig.  1). UNGs 
have evolved in all organisms as the most common form 
of DNA-repair enzymes. Thus far, six groups of the UNG 
superfamily have been discovered and studied to var-
ied extents [17]. However, under constant high dUTP/
dTTP ratios, uracil residues will be incorporated again 
and again instead of thymidines during repair synthesis. 
This vicious circle of uracil re-incorporation and repair is 
likely to lead to an accumulation of many double strand 
breaks and strand exchanges that will eventually result in 
thymidine-less cell death [18].
Given the critical role of dUTPases in cell metabo-
lism, it is not surprising that their presence was shown 
to be essential for the survival of both prokaryotic cells, 
such as Escherichia coli [19], and eukaryotic cells, such 
as Saccharomyces cerevisiae [20]. The enzyme was also 
identified in Plasmodium falciparum, Mycobacterium 
tuberculosis, trypanosome and human cells, as well as in 
DNA viruses and in several groups of retroviruses and 
even some bacteriophages (for an updated review—see 
[7]). Accordingly, inhibiting cellular dUTPase activities 
by drugs can impair cell growth. Therefore, this approach 
might be also applied for treating infections by specific 
pathogens. However, to attain selectivity against the 
pathogens (without debilitating the host cells), this strat-
egy is particularly applicable for treating infections by 
protozoan organisms, as their dUTPases have evolved 
differently from bacteria and eukaryotic cells, thus form-
ing a completely distinct family of proteins [21].
In many cases, from mammal to plant cells, cellular 
dUTPases were shown to be both development and cell 
cycle regulated, with elevated activity in undifferentiated 
dividing cells and low levels in terminally-differentiated 
and/or non-dividing cells [22–24]. Consequently, the lev-
els of cellular dUTPase activity may parallel the size of 
the deoxynucleotide pool, which is high in dividing cells, 
such as activated lymphoblasts, and very low in non-
dividing cells, such as macrophages [25]. In some eukary-
otes, two dUTPase isozymes are generated by mRNA 
alternative splicing or by using alternative promoters. 
Thus, human cells contain nuclear and mitochondrial 
isoforms, where the nuclear one is under cell cycle con-
trol, while the mitochondrial isoform is constitutive [26].
Interestingly, recent reports that use different models 
have done away with the dogma that DNA uracilation is 
always deleterious. Thus, deamination of cytosine bases 
in DNA to uracil by the activation-induced deaminase 
is obligatory for the diversity of immunoglobulin genes 
[27, 28]. Moreover, rather than being dangerous, HIV 
DNA uracilation can benefit the early phase of the viral 
life cycle by inhibiting auto-integration [29]—see below. 
Finally, it was recently demonstrated that Drosophila 
Page 4 of 15Hizi and Herzig  Retrovirology  (2015) 12:70 
melanogaster tolerates high levels of uracil in DNA dur-
ing some developmental stages, suggesting a novel role 
of uracil-containing DNA in Drosophila [30]. Assum-
ing that DNA uracilation is beneficial to some biologi-
cal processes, and since cellular dUTPases are involved 
in this scenario, it may be that dUTPases can also per-
form other unrelated cellular functions. Indeed, a line 
of novel studies has shown that, apart from their pivotal 
role in lowering dUTP levels, cellular dUTPases play 
other roles in regulating several key cellular processes—
by serving as signaling molecules in both prokaryotic 
and eukaryotic cells. Thus, dUTPases were shown to be 
involved in the transfer of mobile genetic elements that 
carry and disseminate virulence genes in prokaryotes and 
in the regulation of the immune system in autoimmun-
ity and apoptosis. These unexpected dUTPase-associated 
“moonlighting” activities (defined as activities of cata-
lytically-active proteins with divergent dual functions) 
open new research opportunities to explore the mecha-
nisms, by which they serve as cellular regulators. Since 
these diverse regulatory functions of dUTPases were 
extensively reviewed recently [31], we will not elabo-
rate here on these exciting and promising novel aspects 
of dUTPases. However, it should be noted that even in 
some DNA viruses, dUTPases affect host-cell interac-
tions via mechanisms independent of dUTP hydrolysis. 
Recent studies have shown that the dUTPases, encoded 
by the gamma-herpesviruses, Epstein-Bar virus, Kaposi’s 
sarcoma-associated herpesvirus and MHV-68, control 
the immune system. This is done by various mechanisms, 
such as, upregulating cytokines, activating NF-kB path-
way, targeting cytokine receptors or down-regulating 
ligands recognized by NK cells (thus, controlling NK 
attacks) and inhibiting type I interferon signaling path-
way [32–34]. dUTPases of other human herpesviruses 
were found to modulate dendritic cell function and 
innate immunity [35]. Moreover, some of the data show 
that enzymatically-inactive dUTPases can also perform 
these regulatory functions, suggesting that their biologi-
cal roles are not merely associated with their dUTPase 
enzymatic activity. Further studies are required to explain 
how these functions evolved to be associated with dUT-
Pase enzymes. Likewise, new interesting evidence, 
regarding the potential involvements of the dUTPases of 
HERVs in human diseases, also alludes to possible cellu-
lar regulations that are independent of catalytic activity 
of dUTPase [36, 37], see below.
Structure and catalysis of dUTPases
While the gamma-phosphate group of nucleoside 
triphosphates is relatively reactive (as in ATP or GTP), 
the alpha-phosphate position, as well as the phosphodi-
ester bonds in nucleic acid, are significantly more inert, 
thus help prevent aberrant modifications [38]. Reactions 
at these sites require powerful enzyme catalysts, such as 
nucleases, polymerases [39] and dUTPases [7]. Almost 
all studied dUTPases, including those of bacteria, human 
and retroviruses, are homo-trimeric proteins [7]. The 
homo-trimers form three identical active sites in a sym-
metric fashion—see Fig.  2. In contrast, herpesviruses 
[40, 41] and Caenorhabditis elegans [42] dUTPases are 
distinct as monomers. Here, trimer-mimicking mono-
mers are formed from a genome that encodes all three 
enzyme monomers, within the same gene (with linker 
Fig. 2 The three-dimensional structures of human and bacterial dUTPases. The homo-trimeric E. coli (2HRM) and Human (3ARN) dUTPases were 
illustrated using the Jsmol internal viewer (http://www.PDB.org). Structures are presented in the front C3 axis orientation, with each subunit in a dif-
ferent color. Ligands (methylene-dUTP in the E. coli enzyme and dUTPase inhibitor in the Human counterpart) are presented in stick configuration.
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regions located among the subunits). A third occasion 
was reported for protozoan dUTPases that function as 
dimers, but contain none of the five conserved sequence 
motifs typical of the dUTPases of the former two groups. 
Thus, they have probably evolved differently from dUT-
Pases in bacteria and other eukaryotes [21, 43].
In general, homo-trimeric or trimer-mimicking dUT-
Pases, including the retroviral ones, are characterized by 
a series of five conserved amino acid motifs [7] (see also 
below). Among mammalian viruses, this common set of 
motifs was initially identified by sequence comparisons 
in herpesviruses, retroviruses and poxviruses. Thought 
initially thought to be “pseudo-protease”, comparisons 
of these motifs with the E. coli dUTPase sequence and 
other known dUTPases revealed their identity as unique 
dUTPase motifs [5, 44]. The importance of these con-
served motifs for the catalytic function was established 
by mutagenesis and by X-ray crystallography of a vari-
ety of dUTPases. To prevent wasteful and undesired 
hydrolysis of energy-rich NTPs or dNTPs, dUTPases 
must be highly specific to their related substrate. This is 
provided by two major mechanisms, reviewed in [7]. In 
short, the first one is a steric exclusion of purines, thy-
mine and ribose and the second is hydrogen bonding that 
is specific to uracil. The steric hindrance is mediated by 
residues from motif 3, which form a tight beta-hairpin 
that binds uracils and deoxyribose and exclude thymine 
and purines. Altogether, the specificity of dUTP binding 
by dUTPases is provided by the uridine moiety that fits 
precisely into the enzyme’s active site [7]. The dUTPase 
binding pockets, present in each of the three subunits 
are highly specific for uracil. Phosphate chain coordina-
tion involves magnesium ions and is analogous to that 
in DNA polymerases. Due to conformational changes 
in the enzyme during catalysis, most crystal structures 
have not resolved the residues in the C-terminus. All 
homo-trimeric dUTPases share similar mechanisms that 
lead to efficient catalysis. In several crystal structures, a 
water molecule is positioned for a nucleophilic attack on 
the dUTP alpha-phosphate that leads to phosphate ester 
hydrolysis. This attack is coordinated by the side chain of 
the highly conserved aspartate that is located in motif 3 
[45, 46]. Interestingly, in herpesvirus dUTPases, though 
the conserved motifs are preserved, they are arranged in 
a different manner. Yet, these motifs still fold similar to 
usual trimeric dUTPases [7, 41].
The dUTPase‑encoding genes in retroviruses
Despite their variable positions, dUTPase-encoding 
genes in many dUTPase-encoding organisms were 
observed to be adjacent to other genes that are involved 
in nucleotide metabolism, such as ribonucleotide reduc-
tase, transcription initiation factors, primase, and DNA 
synthesis flavoprotein [44]. A similar pattern of gene 
localization also exists in retroviral dUTPases, where, 
in most cases, the dUTPase-encoding genes are located 
in the same genome segment encoding for the viral RT, 
IN and or PR proteins. In addition, in the case of beta-
retroviruses the nucleic acids binding protein (NC) is an 
integral part of the viral dUTPase (see Fig. 3).
Unlike most other retroviral enzymes, in the dUTPase-
expressing viruses, the encoding gene is situated in two 
different genomic locations, suggesting two diverse evo-
lution pathways (Fig. 3). In the beta-retroviruses, the gag-
pol genes have three reading frames (gag, pro and pol) [1] 
and the dUTPase protein is encoded by both the gag and 
pro reading frames [47–51]. Consequently, the dUTPase 
protein is actually a trans-frame polypeptide. To be more 
specific, the dUTPase N-terminal segment (of about 90 
residues) is derived from the C-terminus of the Gag poly-
protein. Therefore, this segment is identical to the entire 
viral nucleocapsid (NC) protein [52] (also known in 
these viruses as p14). The C-terminus of the dUTPase is 
encodes by the 5′ portion of the pro gene, ending adjacent 
to the PR-encoding segment. In these viruses, the total 
length of the dUTPase is about 240 amino acids residues 
and it is a proteolytic product of the Gag-PR polyprotein 
precursor. This fused Gag-PR polyprotein results from 
ribosomal frameshifting that occurs during translation 
(see [53]). In contrast, the gag-pol genes of lentiviruses 
have only two reading frames. In the dUTPase-express-
ing lentiviruses, the encoding gene is located within the 
pol gene, between the RT’s RNase H (C-terminal) and the 
IN-encoding parts. Thus, dUTPase is a proteolytic prod-
uct of the Gag–Pol polyprotein precursor. Interestingly, 
the polypeptide length of the majority of the lentivirus-
associated dUTPases is about half (~130 residues) of 
that of the beta-retroviral dUTPases. A rare exception to 
the pattern in non-primate lentiviruses was reported for 
scarcely studied endogenous retroviruses (ERVs) [54–56]. 
Here, the dUTPase gene is located also within the pol 
gene, but rather at its 3′ terminus; hence, it is C-terminal 
to the IN (Fig. 3).
Since all reoviruses have very small genomes, any 
genetic information included in these genomes must be 
vital to the viruses. Therefore, even with little knowl-
edge about the importance of virus-coded dUTPases, 
it is highly likely that they are essential for replication. 
Despite sharing similar mechanisms of replication, only 
several groups of retroviruses encode dUTPases, while 
others lack this enzyme. The major dUTPase-express-
ing retroviruses are the beta-retroviruses and the non-
primate lentiviruses, whereas most other viral groups 
(including primate retroviruses) lack the enzyme. It 
might be that this difference in the requirements for a 
viral-encoded enzyme depends on the cells infected by 
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the viruses. Thus, alpha or gamma-retroviruses that lack 
a viral dUTPase replicate mainly in dividing cells, which 
have high endogenous dUTPase levels, while the dUT-
Pase-expressing retroviruses can infect also non-dividing 
cells with low dUTPase activity (vide supra). In several 
retroviruses, early DNA sequence comparison analyses 
have suggested some resemblance of unidentified genes 
to the viral protease; hence, they were initially termed 
protease-like domains or pseudo-proteases [57]. Only 
later on, the homology to the dUTPase gene was con-
firmed [5]. The key study by Elder and associates has sub-
sequently confirmed the presence of a catalytic dUTPase 
activity in particles of several retroviruses [58].
In the dUTPase-expressing retroviruses, the location of 
encoding gene can affect the level of the protein’s expres-
sion. The gag portion of the gag–pol polycistronic mRNA 
is translated approximately 20 times more than the entire 
polycistron that has to undergo one or two −1 nucleo-
tide frameshifting events to complete translation [1, 53]. 
Thus, in the beta-retroviruses, where the N-terminal part 
of dUTPase is derived from Gag, there is a higher level of 
dUTP expression compared to non-primate lentiviruses. 
Indeed, such a high expression enabled one of us to detect 
the first retroviral dUTPase-related protein in virions of 
mouse mammary tumor virus (MMTV), already in 1987 
[49]. Relatively large amounts of the protein (designated 
at the time as p30, due to its ~30 kDa size) were isolated 
from virions and analyzed by protein sequencing. The 
data showed that this protein is a trans-frame protein, as 
its N-terminal sequence was identical to the viral NC, and 
its C-terminus was derived from the N-terminal half of 
Pro. Only later on, after a study on the presence of dUT-
Pases in retroviral virions was published [58], this MMTV 
p30 was expressed as a recombinant protein and shown to 
possess a dUTPase catalytic activity [48, 51].
Like most dUTPases, all studied retroviral dUTPases 
are homo-trimeric in their three-dimensional struc-
ture (Fig. 4). Accordingly, enzymatically active retroviral 
dUTPases possess the five conserved domains, typical 
to all homo-trimeric or trimer-mimicking dUTPases, 
Fig.  5 [7]. Some families of endogenous retroviruses, 
notably, HERVs K and ERVs share also dUTPase-related 
motifs with the five conserved segments [13, 59, 60]—see 
below. In contrast, the putative dUTPases of the non-
primate lentivirus, bovine immunodeficiency virus (BIV) 
was recently shown by us to have a sequence with only 
dUTPases encoded by retroviruses 
 retroviruses  (e.g., MMTV, MPMV and JSRV)                                                                         
                           Gag 
NC 
                        Pro 
                                                                                   PR
                                             dUTPase  
                                                                                                                          Pol 
RT                                 IN 
Non-primate lenviruses (e. g., EIAV, FIV, Visna, CAEV and BIV) 
                        Gag 
NC 
                                                                                                          Pol 
PR RT                            dUTPase           IN 
Rare endogenous retroviruses  
                       Gag 
                                                   NC 
                                                                                                          Pol 
PR RT                                     IN                 dUTPase  
Fig. 3 The biogenesis of dUTPase-expressing retroviruses. This schematic description of the various precursor polyproteins, encompassing the 
dUTPase proteins, reflects also the position of the dUTPase-encoding genes in the different retroviral groups (described in detail in the text). These 
schemes are not drawn to scale.
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a partial resemblance to these conserved motifs with no 
detectable enzymatic activity [61]—see below. The phy-
logenetic tree of most exogenous retroviral dUTPases, 
discussed below, is shown in Fig. 6. It is highly likely that 
after their separation throughout evolution, the beta-
retroviral dUTPase-encoding gene has evolved separately 
than that of the non-primate lentiviruses. For more gen-
eral phylogenetic trees that include also dUTPases from 
endogenous retroviruses, see [13, 60].
Beta‑retroviruses
All beta-retroviral dUTPases are bi-functional due to 
their chimeric nature. Here, the viral Gag-derived NC 
proteins are fused at their C-termini to the Pro-derived 
dUTPase conserved domains. The dUTPase proteins 
from two prototype viruses of this group, MMTV and 
Mason Pfizer monkey virus (MPMV), were the mostly 
studied. The information pertaining to dUTPases from 
other viruses in this group, Jaagsiekte sheep retrovirus 
(JSRV) and simian retrovirus (SRV), was mainly based 
on sequence homology to the more studied dUTPases 
[47, 62], see Fig.  5. In all beta-retroviruses, the NC is 
81–95 residues long and the Pro-derived segment is 
153–154 residues, out of a total of ~240 residues long 
polypeptide [63]. This means that the NC sequence can 
encompass more than a third of the whole enzymati-
cally-active dUTPase protein. Retroviral NC has a vari-
ety of activities that are central to viral replication, as it 
has a nucleic acid chaperoning activity through its con-
served basic residues and zinc-finger structures, for a 
review—see [52]. This chaperone function, in conjunc-
tion with the protein’s aggregating function, is up-mod-
ulated by successive NC processing events, resulting in 
the condensation of the viral NC. Reverse transcription 
also depends on NC processing. Inducing NC dissocia-
tion from double-stranded DNA leads to the formation 
of the PIC that is capable of host chromosomal integra-
tion. In addition, NC interacts with cellular proteins, 
some of which are involved in viral budding, and also 
with several viral proteins. This collection of activities 
is likely to substantially affect the mature beta-retroviral 
dUTPases (that were shown always to retain the NC). 
Indeed, three retroviral proteins, IN, capsid and NC, 
were found to be capable of physical interaction with 
MPMV dUTPase [64]. This protein is present in stable 
form that resists proteolysis by retroviral and cellular 
proteases in virions as well as in virus-infected cells. 
MPMV dUTPase retains both nucleic acid binding and 
dUTP hydrolyzing catalytic activity. Sequence compari-
son of beta-retroviral dUTPases with other dUTPases 
reveals that the beta-retroviral enzymes have evolved 
to support the proper function of the NC protein fused 
to their dUTPase domain. This evolution affected the 
whole sequence, except for the five conserved motifs 
(see Fig. 5), as shown by the relatively low sequence sim-
ilarity (<30  %) between beta-retroviral and other dUT-
Pases [63]. The modifications, however, do not provoke 
changes in the protein’s overall fold. Yet, due to the basic 
nature of the NC segment, the beta-retroviral dUTPases 
have a much higher, basic pI, compared with the more 
acidic isoelectric points observed in most dUTPases 
[7, 63]. The catalytic rate constant of the recombinant 
protein is, however, about tenfold lower than in other 
dUTPases (including those from lentiviruses) [47]. In 
the case of retroviral dUTPases, this feature may com-
pensate for the higher levels of beta-retroviral dUTPase 
expression, relative to lentiviral dUTPases (see above). 
In all, it may be that the coupling, within a single protein 
subunit, of the nucleic acids binding function with dUT-
Pase activity, could facilitate the attachment of the dUT-
Pase to sites, where DNA synthesis by RT takes place, 
thus hydrolyzing in situ the incoming dUTP.
Fig. 4 The three dimensional structure of three representative retroviral dUTPases. The structures of the homo-trimeric dUTPases of MPMV (3TRL), 
FIV (1F7D) and EIAV (1DUN) were illustrated employing the Jsmol internal viewer (http://www.PDB.org). The structures are presented in the back C3 
axis orientation with each subunit in a different color.
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Enzyme kinetics of recombinant MPMV dUTPase and 
a truncated protein segment (without the NC domain) 
suggested that the NC domain has no adverse effects 
on enzymatic activity and that oligonucleotide bind-
ing to the NC domain may modulate enzymatic activ-
ity [47]. These results failed to provide an explanation 
for the ~tenfold lower catalytic rate constant. A shorter 
linker region located between conserved motifs 4 and 
5 was observed in all beta-retroviral dUTPases relative 
to other dUTPases (including a four-residue deletion 
relative to the non-primate lentiviral dUTPases)—see 
Fig.  5. This may suggest that the missing connecting 
residues can cause a steric constraint that lowers the kcat 
value. High-resolution X-ray structures, combined with 
modeling, indicate that the fusion with NC domains 
alters the conformation of the flexible C-terminus by dis-
turbing the orientation of a critical beta-strand. Accord-
ingly, this segment is capable of double backing upon 
the active site of its own monomer and is stabilized by 
non-covalent interactions formed with the NC terminal 
Fig. 5 Multiple sequence alignment of the retroviral dUTPases. The sequences of dUTPases in the major exogenous retroviruses described in the 
text were analyzed. The five highly-conserved domains typical of dUTPases are indicated below the sequences. In the case of the beta retrovi-
ruses, the NC-derived N-terminal sequences were not included in the alignment. The sequences of the following dUTPases are as follows: EIAV 
(GI: 157830894); FIV (GI: 1942421); Visna (GI:9626549); BIV (GI: 9626219); CAEV (GI: 266706151); JDV (GI:733067);MMTV (GI: :9626965);MPMV (GI: 
9627210);SRV (GI: 334748);JSRV (GI: 9626914). The figure was prepared using the T-COFFEE alignment tool.
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segment. In this case, the homo-trimeric dUTPase fold 
is modulated in a specific manner that allows the accom-
modation of the additional NC segment. Such a co-
folding of the dUTPase terminal segments, which was 
not observed in other dUTPases, results from the pres-
ence of the fused NC domain [63]. Elaborate studies on 
MPMV dUTPases were conducted to show the mecha-
nism of the alpha attack-mediated dUTP hydrolysis that 
is carried out by the enzyme [64]. Here, a combination of 
diverse structural methods, as well as the knowledge of 
other dUTPases, unveiled molecular details of the cata-
lytic nucleophilic attack and identified novel enzyme-
product intermediates.
Although the dUTPase of MMTV was identified and 
characterized before the MPMV counterpart was inves-
tigated [48, 49, 51], substantially fewer studies were per-
formed on the MMTV enzyme. A comparative study 
of the dUTPases of MMTV, herpes simplex and E. coli 
showed that the two viral enzymes are less specific to 
dUTP than the bacterial one [65]. The MMTV enzyme 
has a reduced discrimination against dTTP and UTP, 
while it is still selective against dCTP.
Despite the relatively large body of research conducted 
on beta-retroviral dUTPases, we could not find any stud-
ies on the biological importance of the enzyme to the 
life cycle and infectivity of the viruses. However, this 
missing information can be complemented by the stud-
ies described below on involvement of dUTPases in the 
infectivity of the non-primate lentiviruses.
Lentiviruses
Non‑primate lentiviruses
Among all exogenous lentiviruses, dUTPase-encoding 
genes were observed in only the non-primate lentivi-
ruses. However, there are traits of these genes in some 
ERVs, including in many HERVs (see below). Among 
the non-primate lentiviruses, dUTPase-encoding genes 
are present in feline immunodeficiency virus (FIV) [66], 
puma lentivirus [67], equine infectious anemia virus 
(EIAV) [68, 69], caprine arthritis-encephalitis virus 
(CAEV) [70] and visna virus of sheep [71]. Additionally, 
in the bovine lentiviruses, BIV that is associated with a 
debilitating cattle disease [72], and Jembrana disease 
virus (JDV), a homologous dUTPase-encoding gene is 
present [73, 74], see above (Fig. 5). In a rare case of the 
infectious small-ruminant genotype E lentivirus (iso-
lated from goats and sheep), almost the entire dUTPase 
genome is deleted [75]. As mentioned above, the dUT-
Pase encoding gene in this retroviral group is part of the 
pol gene and is situated between the RT and IN encoding 
segments (Fig. 3). Another feature that sets the non-pri-
mate lentiviral dUTPases apart from the beta-retroviral 
counterparts (and from other known dUTPases as well) 
is the relatively shorter polypeptide subunit, of about 
130 residues (which is roughly half of the beta-retroviral 
dUTPases). Despite this major difference, similar to other 
studied dUTPases, the three-dimensional structure of 
EIAV dUTPase exhibits a homo-trimeric arrangement, 
where each subunit folds into a twisted antiparallel beta-
barrel with the N and C-terminal portions interacting 
with the adjacent subunits [76]. A generally similar struc-
ture was reported also for FIV dUTPase [77], see also 
Fig. 4.
The majority of the biochemical studies on the dUT-
Pases of the non-primate lentiviruses were conducted on 
recombinant EIAV dUTPase. This enzyme was shown 
to be highly specific to dUTP and sensitive to inhibi-
tion by dUDP, with little inhibition by other nucleotides 
or the reaction products, dUMP and PPi [78]. In this 
study, mutational analyses were also performed by tar-
geting a conserved domain present at the C-terminus of 
all dUTPases. This domain shares high homology with 
the phosphate binding loops (P-loops) of several ATP 
and GTP-binding phosphatases. The P-loop-like motif 
of dUTPases is glycine rich, but lacks the invariant lysine 
found in authentic P-loops. Deletion of this motif led to a 
loss of the enzymatic activity. In addition, a series of point 
mutations in EIAV dUTPase that inactivate these P-loops 
also abolished the dUTPase activity; thus establishing the 
importance of these loops for catalysis. Another study 
compared EIAV dUTPase with the E. coli counterpart 
[79]. The results showed that the viral enzyme was as 
potent as the bacterial one in hydrolyzing dUTP, albeit 
less specific. The inhibition of the EIAV enzyme by dTTP, 
dUMP and a synthetic analog is stronger by one order of 
magnitude than that of the bacterial counterpart. Tran-
sient kinetics of EIAV dUTPase showed that the rate con-
stants for the association and dissociation of substrate 
and inhibitors were consistent with a one-step substrate 
Fig. 6 Phylogenetic tree of dUTPase sequences from exogenous 
infective retroviruses. This phylogenetic tree was constructed using 
amino acid multiple alignments and the neighbor-joining method 
with ETE-toolkit (http://etetoolkit.org/treeview/), with the sequences 
shown in Fig. 5. Scale bar represents the p-distance (the observed 
number of nucleotide differences per site).
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binding mechanism [80]. After the flexible C-terminal 
part of the protein was removed by a limited proteolysis, 
the dUTPase activity was totally quenched, although sub-
strate binding was hardly affected. This suggests that this 
terminus is indispensable for catalysis but not a for sub-
strate binding.
Most studies on the effects of dUTPases on the biology 
of non-primate lentiviruses concluded that this enzyme 
is critical for replication only in non-dividing cells (such 
as primary macrophages). In contrast, dUTPase-defec-
tive viruses can grow quite well in dividing cells, where 
the dUTPase activity is supplied by the infected cell. 
This result is consistent with the data presented above, 
showing that cellular dUTPases are cell cycle regulated, 
with an elevated activity in dividing cells and low levels 
in terminally differentiated non-dividing cells. This find-
ing regarding the non-primate lentiviruses was reported 
for the dUTPase of CAEV and visna [70], EIAV [68, 81, 
82] and FIV [66]. The effects of viral dUTPase in virus-
infected animals were also evident. Thus, in FIV-infected 
cats, virus burden was reduced due to dUTPase impair-
ment, particularly in tissues, such as spleen and salivary 
gland [83]. The viral RNA load in plasma of Shetland 
ponies, infected with a dUTPase-defective EIAV, was 10 
to 100-fold lower than in animals infected with the wild-
type virus [68]. In the case of CAEV, the dUTPase is nec-
essary for the development of bilateral arthritis lesions 
in the carpus of infected goats [84]. However, this is not 
always the case. Thus, visna virus dUTPase was found 
to be dispensable for neuro-pathogenicity [71]. Like-
wise, the dUTPase gene of FIV is not essential for neuro-
pathogenesis in cats [85].
As expected, the importance of the dUTPase to the 
retroviruses is linked to the misincorporation of dUTP 
instead of dTTP. Several studies have linked the lack of 
dUTPase activity with an increased incidence of muta-
tions in the viral DNA, especially G to A substitutions 
when the viruses replicate in terminally differentiated 
non-dividing cells. This result was found in CAEV [84], 
EIAV [81] and FIV [83]. These findings indicate that 
uracil accumulation in the viral DNA can be detrimen-
tal to the viral life cycle, although the precise mecha-
nism it still not fully understood. HIV-1 RT was shown 
to introduce G to A mutations in a simple in vitro DNA 
synthesis, using highly-biased dNTP concentrations [86]. 
This can explain why many of the spontaneous muta-
tions found in HIV-1 are G to A. As mentioned above, 
the levels of cellular dUTPase activity may parallel the 
size of the deoxynucleotide pool, which is high in divid-
ing cells, such as activated lymphoblasts, and very low in 
non-dividing cells, such as macrophages [25]. Therefore, 
it is possible that in these dNTP-deficient cells, there 
are dU misincorporations across the template G, due to 
low dCTP concentrations, high dUTP (due to the lack 
of dUTPase) and the relative stability of dU-G mispairs, 
These conditions will eventually result in selective G to A 
transitions [84]. Apparently, despite the numerous stud-
ies conducted on dUTP misincorporation, this hypoth-
esis still calls for further experimental support.
The distinct case of BIV The putative dUTPase genes of 
BIV and JDV are distinct, though both follow the pattern 
of non-primate lentiviruses [87, 88]. As in all non-primate 
lentiviruses, these genes are located between the RT and 
IN-encoding genes. However, in both cases the encoded 
polypeptide is substantially shorter than the ~130-resi-
dues protein of other lentiviruses, as it is only about 74 
residues long [61, 73, 74]—see Fig.  5. This truncated 
polypeptide lacks extensive parts of the five conserved 
motifs, characteristic of the homo-trimeric dUTPases, or 
the whole motifs [61]. As far as we know, no other dUT-
Pase-related protein, including all viral, prokaryotic or 
eukaryotic enzymes is so small. Still, it is highly likely that 
this dUTPase-related peptide has an important biological 
role, since it is conserved in both BIV and JDV [87, 88]. 
Our recent study showed that recombinant wild-type 
BIV dUTPase and infectious wild-type BIV virions were 
both dUTPase-defective, as no detectable enzymatic 
activity could be shown [61]. To assess the importance 
of the dUTPase gene to BIV replication, we generated 
virions of wild-type BIV or BIV with mutations in this 
gene. The two mutant dUTPases were the double mutant, 
D48E/N57S (located in the putative dUTPase active site 
and its vicinity) and a 36 residues deletion. Both mutant 
viruses were defective, as no progeny viruses were gen-
erated. Surprisingly, the cells infected with the mutant 
virions carry in their genomic DNA levels of integrated 
BIV DNA that were as high as in wild-type BIV-infected 
cells. This result shows that the dUTPase-mutated BIV 
strains could infect cells, as viral cDNA was synthesized 
and integrated. Yet, no new virions were generated from 
the infected cells [61]. Interestingly, all experiments were 
conducted in dividing cells, where, as mentioned above, 
the endogenous cellular dUTPase levels are supposed to 
be high. Therefore, according to this prediction, there 
should be only a minor effect of mutating the dUTPase-
encoding gene, even in the case of an enzymatically-
active dUTPase activity (let alone in the present case, 
where no activity was noticeable).
To explain these puzzling results, we speculated that 
either the integrated cDNA of the BIV mutants is defec-
tive (due to potential multiple mutations introduced dur-
ing reverse-transcription) or that dUTPase mutations 
led to blocks in viral replication at steps post integration. 
These suppositions may implicate the involvement of 
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BIV’s dUTPase in processes other than dUTP hydroly-
sis, thus highlighting its importance to BIV replica-
tion, despite the lack of any detectable catalytic activity. 
At this stage, several unexplored alternatives are open. 
For example, it might be that the viral protein interacts 
with cellular proteins (like UNG-see above) or it par-
ticipates in late (post integration) stages of the retroviral 
replication cycle. Likewise, given the evidence on novel 
“moonlighting” activities of dUTPases, see above, such 
activities may be associated with the dUTPase of BIV. 
The information listed below on the possible involvement 
of HERV-K dUTPases with human diseases can also sup-
port this possibility. In any case, further studies are being 
performed now by us to answer the raised questions.
Human and primate lentiviruses
Primate exogenous lentiviruses (such as HIV-1, HIV-2 
and simian immunodeficiency virus-SIV) evolved differ-
ently than other lentiviruses and are devoid of a dUT-
Pase-encoding gene. Yet, one study proposed a weak 
albeit significant sequence similarity between HIV-1 
gp120 envelop protein and human dUTPase [89]. This 
information may suggest that an ancestral dUTPase gene 
has evolved into the present CD4 receptor interacting 
region of gp120. Since these primate viruses can replicate 
also in non-dividing cells, where the dUTP/dTTP ratio is 
high (due to low cellular dUTPases, see above), it is likely 
that they can utilize other equivalent means to coun-
teract the emergence of uracilated viral DNA genomes. 
Indeed, as an alternative, they can recruit one of the 
cellular UNG enzymes (UNG2) that are involved in the 
base-excision repair pathway (see above and Fig.  1). In 
HIV-1, there are conflicting reports about the identity of 
the viral protein that is responsible for this recruitment. 
Some studies implicated the viral IN [90–92], whereas 
others the accessory protein, Vpr [8, 93, 94]. Interest-
ingly, the HIV-1 associated UNG2 could be replaced by 
packaging into the virions a heterologous dUTPase from 
CAEV. This finding suggests that UNG2 can counteract 
the dUTP misincorporation that results from the lack of 
the dUTPase [95]. A recent study established the essen-
tial steps through which UNG2 initiates the degradation 
of HIV-1 cDNA containing misincorporated dUTP and 
prevents viral integration [96].
Remarkably, there is another entirely independent 
mechanism to form uracil-containing DNA in many len-
tiviruses that eventually leads also to G to A mutations. 
This process is mediated by incorporating the cellular 
restriction proteins, APOBEC cytosine deaminases into 
Vif-deficient virions. This eventually leads to the impair-
ment of virus replication due to C to U deamination of 
the synthesized viral cDNA. The APOBEC cytosine 
deaminase activity is largely specific to single-stranded 
DNA substrates and requires a minimum of five contigu-
ous deoxy-nucleotides (three on the 5′ side of the target 
cytosine and one base on the 3′ side of the target cyto-
sine). In wild-type viruses, the viral Vif protein recruits 
cellular CBF-β to form an E3 ubiquitin ligase complex 
that usually leads the APOBEC degradation. Due to its 
cardinal importance to HIV infectivity, this innate cellu-
lar anti-viral activity was heavily investigated, as part of 
the intensive investigations of cellular factors that restrict 
HIV-1 (for comprehensive reviews—see [97–100]). 
Therefore, we will not elaborate here on this process.
Taken together, as in the case of the other retroviruses, 
it is believed that uracilation of the viral cDNA is detri-
mental to the retroviral life cycle. This conclusion was 
also supported by in  vitro evidence showing that the 
incorporation of uracils into minus-strand DNA during 
HIV-1 reverse transcription affects the specificity of plus 
strand synthesis initiation [101]. An interesting revision 
to the belief that uracilation has negative consequences 
was proposed by showing that HIV-1 could tolerate, or 
even benefits, from non-mutagenic uracil incorporation 
during reverse transcription [29]. Here, uracilation of 
the viral cDNA obstructs the strand transfer of the DNA 
ends that is catalyzed by the viral IN, thereby inhibiting 
the suicidal auto-integration side pathway and facilitating 
the correct chromosomal integration of viral cDNA and, 
consequently, the viral replication.
Endogenous human retroviruses
About 8 % of the human genome comprise HERVs that 
represent fossilized sequences of ancient exogenous ret-
roviruses [15], see also above. These elements, distrib-
uted in about 400,000 loci and transmitted vertically in 
a Mendelian manner, are classified into 30–40 families. 
Each family can encompass up to thousands of loci [102]. 
HERVs were suggested to be associated with a variety of 
human diseases, including, autoimmune diseases, neu-
rological disorders and multiple malignancies, as well 
as involvement in placentation [16, 103]. Several HERV 
families were reported to harbor dUTPase domains. A 
sequence survey of various HERV families for the pres-
ence of dUTPase has found that ancestors of all HERV-K 
families but one encode dUTPases [60]. This phyloge-
netic analysis shows a monophyletic origin for the dif-
ferent HERV-K dUTPases. Sequences of the consensus 
dUTPase domains suggest that the various exogenous 
ancestors of HERV-K once encoded active enzymes. 
Interestingly, a recombinantly-expressed dUTPase was 
catalytically-active when a consensus sequence was con-
structed from independent genomic clones of HERV-K. 
This presumably-ancestral wild type HERV-K dUTPases 
was meticulously studied employing biochemical, muta-
genic and structural approaches [59]. Despite this study, 
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there are no available convincing reports that show the 
intracellular expression of HERV-encoded and catalyti-
cally active dUTPases. Even so, it was speculated, with no 
experimental proof, that HIV can lack a dUTPase-encod-
ing gene, because the host human cells, infected by this 
exogenous virus, already express an endogenous dUT-
Pase that is encoded by a HERV [104].
Possible links of HERVs dUTPases to human diseases
As mentioned, the high presence of HERVs in numerous 
sites over the human genes has suggested their poten-
tial linkages to human diseases. Interestingly, stimulat-
ing new evidence suggest an unexplored specific linkage 
between the HERV-K encoded dUTPase and human 
psoriasis. Psoriasis is a chronic inflammatory immune 
disease of the skin that is characterized by an elaborate 
interplay between multiple-risk genes and their interac-
tions with environmental factors. The psoriasis suscepti-
bility locus 1 (PSORS1) mutation resided within a region 
close to human leukocyte antigen-C, designated risk hap-
lotype (RH) 1/2, which is located within marker M6S168. 
This target region harbors fragments of a HERV-K. Two 
single nucleotide polymorphisms with alleles differ-
ing between high and low-risk haplotypes are located 
within the HERV-K dUTPase [105]. One of these haplo-
types encodes a non-conserved Glu to Arg mutation. The 
HERV-K dUTPase is expressed in peripheral blood and 
in normal as well as in lesional psoriatic skin, thus sug-
gesting that it can be a candidate gene for the PSORS1 
mutation. To investigate the direct role of the HERV-K 
dUTPase in psoriasis, purified recombinant dUTPase 
versions with the wild-type sequence, and with muta-
tions, reflecting the genotype characteristics of high 
and low-risk haplotypes, were evaluated to see whether 
they could modulate innate and/or adaptive immune 
responses [36]. The outcomes show that both wild-type 
type and mutant HERV-K dUTPase proteins induced 
NF-kB activation through Toll-like receptor 2 that is 
independent of the enzymatic activity. In both cases, 
the treatment of human primary cells with the recombi-
nant dUTPase proteins triggered a secretion of TH1 and 
TH17 cytokines that are involved in forming psoriatic 
plaques, including IL-23, IL-12p40, IL-17, tumor necrosis 
factor-alpha, IL-8, and CCL20. This result was observed 
in dendritic/Langerhans-like cells and, to a lesser extent, 
in keratinocytes. An independent study described a vari-
ant discovery and case–control association of HERV-
K dUTPase variants in 708 psoriasis cases and 349 
healthy controls. Five common HERV-K dUTPase vari-
ants exhibited a high association with psoriasis, with the 
strongest association with a missense single-nucleotide 
polymorphism that leads to a K158R mutation. Haplo-
type analysis revealed that HERV-K haplotypes with the 
non-risk alleles significantly reduced the risk of psoriasis 
[37]. Moreover, functional testing showed higher anti-
body responses against recombinant HERV-K dUTPase 
in psoriasis patients compared with controls, as well as 
higher T cell responses against a single HERV-K dUT-
Pase peptide.
The described studies support a novel and independ-
ent role for the HERV-K dUTPase in the susceptibility 
to psoriasis. Nevertheless, the mechanisms underlying 
the linkage between the HERV-K dUTPase and psoria-
sis are still elusive, especially since it does not require 
an enzymatically-active protein. In this respect, there is 
a partial similarity to our recent study on effects of the 
enzymatically-inactive BIV dUTPase [61], see also above. 
It is likely that, as described earlier for several outstand-
ing cases [31], the HERV-K protein serves as a signaling 
molecule that is involved in affecting basic cellular func-
tions. Apparently, the most exciting question is how the 
retroviral enzyme evolved to function in these “moon-
lighting” activities. It is expected that further detailed 
phylogenetically studies on retroviral dUTPases (similar 
to those already performed [13, 60]), in combination with 
intensive cell biology, will uncover new answers for this 
fundamental question.
Conclusions
The data summarized in this review describe the 
importance of dUTPases to the retroviral life cycle in 
conjunction with cellular dUTPases, dUTP levels and 
mutagenesis (caused by dUTP misincorporation into 
DNA during the process of reverse transcription). 
Since both host cells and the infecting retroviruses 
have common goals to prevent and/or correct the det-
rimental effects caused by high dUTP levels, they have 
mutually developed analogous strategies to accomplish 
this objective. Interestingly, only several groups of ret-
roviruses have evolved to express their own dUTPase, 
while others either take advantage of the cellular dUT-
Pase or recruit a cellular UNG that initiates the cor-
rection of dUTP misincorporation. The association of 
HERV-K dUTPase with human psoriasis adds another 
twist to these relatively straightforward lines of reason-
ing, by highlighting the protein’s involvement in cel-
lular signaling processes, which is not related to the 
catalytic dUTPase activity. The questions surround-
ing the function of the unique dUTPase of BIV lead 
also to new, yet unexplored directions. Taken together, 
there are still many research avenues that should be 
undertaken to better understand the diverse molecular 
mechanisms associated with retroviral dUTPases. Con-
ceivable, the development of specific inhibitors of ret-
roviral dUTPase activity, and/or dUTPase-interacting 
molecules, could greatly help in answering some of the 
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raised questions and possibly help in designing novel 
anti-retroviral drugs.
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